These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 22823500)
41. Melatonin MT Chen M; Cecon E; Karamitri A; Gao W; Gerbier R; Ahmad R; Jockers R J Pineal Res; 2020 May; 68(4):e12641. PubMed ID: 32080899 [TBL] [Abstract][Full Text] [Related]
42. Intracoronary melatonin increases coronary blood flow and cardiac function through β-adrenoreceptors, MT1/MT2 receptors, and nitric oxide in anesthetized pigs. Grossini E; Molinari C; Uberti F; Mary DA; Vacca G; Caimmi PP J Pineal Res; 2011 Sep; 51(2):246-57. PubMed ID: 21545522 [TBL] [Abstract][Full Text] [Related]
43. Changes in melatonin receptor expression in a murine model of glaucoma. Martínez-Águila A; Fonseca B; Pérez de Lara MJ; Miras-Portugal MT; Gómez-Villafuertes R; Carracedo G; Pintor J Mol Vis; 2020; 26():530-539. PubMed ID: 32818016 [TBL] [Abstract][Full Text] [Related]
44. Gene structures, biochemical characterization and distribution of rat melatonin receptors. Ishii H; Tanaka N; Kobayashi M; Kato M; Sakuma Y J Physiol Sci; 2009 Jan; 59(1):37-47. PubMed ID: 19340560 [TBL] [Abstract][Full Text] [Related]
45. Melatonin and type 2 diabetes - a possible link? Peschke E; Stumpf I; Bazwinsky I; Litvak L; Dralle H; Mühlbauer E J Pineal Res; 2007 Apr; 42(4):350-8. PubMed ID: 17439551 [TBL] [Abstract][Full Text] [Related]
46. MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential. Zlotos DP; Jockers R; Cecon E; Rivara S; Witt-Enderby PA J Med Chem; 2014 Apr; 57(8):3161-85. PubMed ID: 24228714 [TBL] [Abstract][Full Text] [Related]
47. Altered MT1 and MT2 melatonin receptors expression in the hippocampus of pilocarpine-induced epileptic rats. Rocha AKAA; de Lima E; Amaral F; Peres R; Cipolla-Neto J; Amado D Epilepsy Behav; 2017 Jun; 71(Pt A):23-34. PubMed ID: 28460319 [TBL] [Abstract][Full Text] [Related]
48. Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists. Nonno R; Pannacci M; Lucini V; Angeloni D; Fraschini F; Stankov BM Br J Pharmacol; 1999 Jul; 127(5):1288-94. PubMed ID: 10455277 [TBL] [Abstract][Full Text] [Related]
50. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors. Sumaya IC; Masana MI; Dubocovich ML J Pineal Res; 2005 Sep; 39(2):170-7. PubMed ID: 16098095 [TBL] [Abstract][Full Text] [Related]
51. Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation. Soliman A; Lacasse AA; Lanoix D; Sagrillo-Fagundes L; Boulard V; Vaillancourt C J Pineal Res; 2015 Aug; 59(1):38-46. PubMed ID: 25833399 [TBL] [Abstract][Full Text] [Related]
52. Neuroprotection by melatonin on astrocytoma cell death. Radogna F; Nuccitelli S; Mengoni F; Ghibelli L Ann N Y Acad Sci; 2009 Aug; 1171():509-13. PubMed ID: 19723097 [TBL] [Abstract][Full Text] [Related]
53. Melatonin influences somatostatin secretion from human pancreatic δ-cells via MT1 and MT2 receptors. Zibolka J; Mühlbauer E; Peschke E J Pineal Res; 2015 Mar; 58(2):198-209. PubMed ID: 25585597 [TBL] [Abstract][Full Text] [Related]
54. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Jockers R; Maurice P; Boutin JA; Delagrange P Br J Pharmacol; 2008 Jul; 154(6):1182-95. PubMed ID: 18493248 [TBL] [Abstract][Full Text] [Related]
55. Melatonin Signaling Controls the Daily Rhythm in Blood Glucose Levels Independent of Peripheral Clocks. Owino S; Contreras-Alcantara S; Baba K; Tosini G PLoS One; 2016; 11(1):e0148214. PubMed ID: 26824606 [TBL] [Abstract][Full Text] [Related]
56. Inverse agonist exposure enhances ligand binding and G protein activation of the human MT1 melatonin receptor, but leads to receptor down-regulation. Kokkola T; Vaittinen M; Laitinen JT J Pineal Res; 2007 Oct; 43(3):255-62. PubMed ID: 17803522 [TBL] [Abstract][Full Text] [Related]
57. Evidence of the receptor-mediated influence of melatonin on pancreatic glucagon secretion via the Gαq protein-coupled and PI3K signaling pathways. Bähr I; Mühlbauer E; Albrecht E; Peschke E J Pineal Res; 2012 Nov; 53(4):390-8. PubMed ID: 22672634 [TBL] [Abstract][Full Text] [Related]
58. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity. Barberino RS; Menezes VG; Ribeiro AEAS; Palheta RC; Jiang X; Smitz JEJ; Matos MHT Biol Reprod; 2017 Jun; 96(6):1244-1255. PubMed ID: 28595266 [TBL] [Abstract][Full Text] [Related]
59. Mammalian melatonin receptors: molecular biology and signal transduction. von Gall C; Stehle JH; Weaver DR Cell Tissue Res; 2002 Jul; 309(1):151-62. PubMed ID: 12111545 [TBL] [Abstract][Full Text] [Related]
60. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells. Imbesi M; Uz T; Manev H Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]